Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study

Fig. 4

The dynamic changes of cerebrospinal fluid white cell count (CSF WCC) at baseline (week 0) and through antifungal therapy (weeks 1–10) in patients with cryptococcal meningitis (CM). CM patients in the good outcome group had higher CSF WCC in weeks 0–6 and week 10 than those in the poor outcome group (P < 0.05). Missing data in each group and each week were not used in Figure 4. No CSF WCC records were available in week 9

Back to article page